LAYLA ABUSHAMAT to Cardiovascular Diseases
This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Cardiovascular Diseases.
Connection Strength
2.866
-
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity? Curr Cardiol Rep. 2024 Sep; 26(9):1011-1019.
Score: 0.379
-
LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon. J Am Coll Cardiol. 2024 02 13; 83(6):665-668.
Score: 0.368
-
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.
Score: 0.366
-
Obesity dominates early effects on cardiac structure and arterial stiffness in people with type 2 diabetes. J Hypertens. 2023 11 01; 41(11):1775-1784.
Score: 0.355
-
Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes. J Am Heart Assoc. 2023 05 16; 12(10):e029944.
Score: 0.349
-
Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care? J Am Coll Cardiol. 2023 04 11; 81(14):1350-1352.
Score: 0.347
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
Score: 0.097
-
Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey. Ann Intern Med. 2024 Oct; 177(10):1444-1448.
Score: 0.096
-
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. Eur J Prev Cardiol. 2024 Mar 27; 31(5):e33-e35.
Score: 0.093
-
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270.
Score: 0.092
-
Social Vulnerability and Cardiovascular-Related Mortality Among Older Adults in the United States. Am J Med. 2024 02; 137(2):122-127.e1.
Score: 0.090
-
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
Score: 0.081
-
Evolving Concepts of Type 2 Diabetes Management. Med Clin North Am. 2021 Nov; 105(6):955-966.
Score: 0.078
-
Obesity Management in Cardiometabolic Disease: State of the Art. Curr Atheroscler Rep. 2021 08 04; 23(10):59.
Score: 0.077